Literature DB >> 22552586

Myeloid-derived suppressor cells control microbial sepsis.

Marc Derive1, Youcef Bouazza, Corentine Alauzet, Sébastien Gibot.   

Abstract

PURPOSE: To investigate the role of myeloid-derived suppressor cells (MDSCs) during sepsis in mice. MDSCs are a heterogeneous population of cells that expand during cancer, inflammation and infection. These cells, by their ability to suppress T lymphocyte proliferation, regulate immune responses during various diseases. Their role during microbial infections is scarcely known.
METHODS: Septic shock was induced by caecal ligation and puncture in adult male BALB/c mice; sham-operated animals served as controls. Animals were killed under anaesthesia to harvest blood and organs.
RESULTS: Polymicrobial sepsis induced a progressive accumulation of MDSCs in spleens that were found to be enlarged in surviving mice. MDSCs harvested at day 10 after the onset of infection were highly responsive to LPS in terms of cytokines secretion, NF-kB activation, ROS production and arginase I activity, whereas early-appearing (day 3) MDSCs poorly responded to this stimulus. By contrast, both day 3 and day 10 MDSCs were able to inhibit T cell proliferation. Adoptive transfer of day 10 MDSCs to septic mice attenuated peritoneal cytokine production, increased bacterial clearance and dramatically improved survival rate.
CONCLUSION: These results provide new information on the role of MDSCs, suggesting a protective effect during sepsis. Pharmacologic agents known to promote the expansion of MDSCs should thus be further studied for sepsis treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552586     DOI: 10.1007/s00134-012-2574-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  31 in total

Review 1.  Compensatory anti-inflammatory response syndrome.

Authors:  Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  Thromb Haemost       Date:  2009-01       Impact factor: 5.249

Review 2.  MDSC in autoimmunity.

Authors:  James G Cripps; James D Gorham
Journal:  Int Immunopharmacol       Date:  2011-02-21       Impact factor: 4.932

3.  A ribonucleotide reductase inhibitor reverses burn-induced inflammatory defects.

Authors:  Greg Noel; Quan Wang; Andrew Osterburg; Sandy Schwemberger; Laura James; Lauren Haar; Nicholas Giacalone; Ingrid Thomas; Cora Ogle
Journal:  Shock       Date:  2010-11       Impact factor: 3.454

4.  Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus.

Authors:  S Chen; S M F Akbar; M Abe; Y Hiasa; M Onji
Journal:  Clin Exp Immunol       Date:  2011-07-15       Impact factor: 4.330

Review 5.  A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma.

Authors:  Alex G Cuenca; Matthew J Delano; Kindra M Kelly-Scumpia; Claudia Moreno; Philip O Scumpia; Drake M Laface; Paul G Heyworth; Philip A Efron; Lyle L Moldawer
Journal:  Mol Med       Date:  2010-11-12       Impact factor: 6.354

6.  Sepsis induces early alterations in innate immunity that impact mortality to secondary infection.

Authors:  Matthew J Delano; Terri Thayer; Sonia Gabrilovich; Kindra M Kelly-Scumpia; Robert D Winfield; Philip O Scumpia; Alex G Cuenca; Elizabeth Warner; Shannon M Wallet; Mark A Wallet; Kerri A O'Malley; Reuben Ramphal; Michael Clare-Salzer; Philip A Efron; Clayton E Mathews; Lyle L Moldawer
Journal:  J Immunol       Date:  2010-11-24       Impact factor: 5.422

Review 7.  The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity.

Authors:  Je-In Youn; Dmitry I Gabrilovich
Journal:  Eur J Immunol       Date:  2010-11       Impact factor: 5.532

8.  Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+ )immature myeloid suppressor cells.

Authors:  Oscar Goñi; Pilar Alcaide; Manuel Fresno
Journal:  Int Immunol       Date:  2002-10       Impact factor: 4.823

9.  Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin.

Authors:  Veronica Munera; Petar J Popovic; Jodie Bryk; John Pribis; David Caba; Benjamin M Matta; Mazen Zenati; Juan B Ochoa
Journal:  Ann Surg       Date:  2010-01       Impact factor: 12.969

10.  MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis.

Authors:  Matthew J Delano; Philip O Scumpia; Jason S Weinstein; Dominique Coco; Srinivas Nagaraj; Kindra M Kelly-Scumpia; Kerri A O'Malley; James L Wynn; Svetlana Antonenko; Samer Z Al-Quran; Ryan Swan; Chun-Shiang Chung; Mark A Atkinson; Reuben Ramphal; Dmitry I Gabrilovich; Wesley H Reeves; Alfred Ayala; Joseph Phillips; Drake Laface; Paul G Heyworth; Michael Clare-Salzler; Lyle L Moldawer
Journal:  J Exp Med       Date:  2007-06-04       Impact factor: 14.307

View more
  36 in total

Review 1.  Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting.

Authors:  Vijay Kumar
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

2.  HuR promotes miRNA-mediated upregulation of NFI-A protein expression in MDSCs during murine sepsis.

Authors:  Isatou Bah; Tuqa Alkhateeb; Ajinkya Kumbhare; Dima Youssef; Zhi Q Yao; Gregory A Hawkin; Charles E McCall; Mohamed El Gazzar
Journal:  Mol Immunol       Date:  2020-05-28       Impact factor: 4.407

3.  Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome.

Authors:  Juan C Mira; Lori F Gentile; Brittany J Mathias; Philip A Efron; Scott C Brakenridge; Alicia M Mohr; Frederick A Moore; Lyle L Moldawer
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

4.  MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis.

Authors:  Clara McClure; Laura Brudecki; Donald A Ferguson; Zhi Q Yao; Jonathan P Moorman; Charles E McCall; Mohamed El Gazzar
Journal:  Infect Immun       Date:  2014-06-30       Impact factor: 3.441

Review 5.  Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells.

Authors:  Jie Zhou; Yulia Nefedova; Aihua Lei; Dmitry Gabrilovich
Journal:  Semin Immunol       Date:  2017-12-15       Impact factor: 11.130

6.  Acute-Phase Deaths from Murine Polymicrobial Sepsis Are Characterized by Innate Immune Suppression Rather Than Exhaustion.

Authors:  Evan L Chiswick; Juan R Mella; John Bernardo; Daniel G Remick
Journal:  J Immunol       Date:  2015-09-14       Impact factor: 5.422

7.  Cyclooxygenase-2 blockade inhibits accumulation and function of myeloid-derived suppressor cells and restores T cell response after traumatic stress.

Authors:  Ren-Jie Li; Lin Liu; Wei Gao; Xian-Zhou Song; Xiang-Jun Bai; Zhan-Fei Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-04-08

8.  Deep Immune Profiling of an Arginine-Enriched Nutritional Intervention in Patients Undergoing Surgery.

Authors:  Nima Aghaeepour; Cindy Kin; Edward A Ganio; Kent P Jensen; Dyani K Gaudilliere; Martha Tingle; Amy Tsai; Hope L Lancero; Benjamin Choisy; Leslie S McNeil; Robin Okada; Andrew A Shelton; Garry P Nolan; Martin S Angst; Brice L Gaudilliere
Journal:  J Immunol       Date:  2017-08-09       Impact factor: 5.422

Review 9.  IMMUNE CELL PHENOTYPE AND FUNCTION IN SEPSIS.

Authors:  Thomas Rimmelé; Didier Payen; Vincenzo Cantaluppi; John Marshall; Hernando Gomez; Alonso Gomez; Patrick Murray; John A Kellum
Journal:  Shock       Date:  2016-03       Impact factor: 3.454

Review 10.  Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies.

Authors:  Fabienne Venet; Anne-Claire Lukaszewicz; Didier Payen; Richard Hotchkiss; Guillaume Monneret
Journal:  Curr Opin Immunol       Date:  2013-05-28       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.